← 返回

NK 细胞与急性白血病细胞之间的分子相互作用:KIR2DL5 显著限制 NK 细胞反应

英文原题:Molecular Interactions Between NK Cells and Acute Leukemic Cells: KIR2DL5 Drastically Limits NK Cell Responses.

查看英文原题

Molecular Interactions Between NK Cells and Acute Leukemic Cells: KIR2DL5 Drastically Limits NK Cell Responses.

PubMed 2025/07/29(内容时间) J Clin Immunol Q2 · IF 4.1(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

自然杀伤(NK)细胞能够天然识别并清除白血病细胞。然而,由于大量调节NK功能的活化性和抑制性NK受体以及急性淋巴细胞白血病和急性髓细胞白血病中差异表达的相应配体的多样性,调控这些反应的分子相互作用具有多样性。

我们鉴定出静息NKG2A+ NK细胞和NKG2A+ KIR+ NK细胞亚群分别在清除淋系和髓系白血病细胞方面最为有效。NKG2A+ KIR± CD57-细胞亚群显示活化性受体的高表达和功能性转录组学特征,但在KIR2DL5表达上存在差异。KIR2DL5+ NK细胞的频率随着表达KIR数量的增加而增加。

此外,KIR2DL5优先与KIR2DL1共表达,并受NKG2A负向调控。值得注意的是,无论考虑哪种NK细胞亚群,CD57表达均与受体表达降低相关,这与其细胞毒性潜力降低相一致。

此外,NK细胞与白血病细胞之间的分子相互作用影响NK细胞反应,特别是抑制性KIR2DL5-PVR轴。整合这些数据对于优化基于NK细胞的免疫治疗具有重要意义,因为NK细胞供者的选择是改善这些疗法的关键参数。

展开英文摘要原文

Natural Killer (NK) cells naturally recognize and eliminate leukemic cells.

However, the molecular interactions that govern these responses are diverse due to the large number of activating and inhibitory NK receptors that modulate NK functions and the diversity of corresponding ligands that are differentially expressed in acute lymphoblastic and myeloblastic leukemias.

We identified resting NKG2A + NK cells and NKG2A + KIR + NK cell subsets as the most effective in eliminating lymphoid and myeloid leukemic cells respectively. The NKG2A + KIR ± CD57 - cell subsets show high expression of activating receptors and a functional transcriptomic profile, but differ in KIR2DL5 expression. The frequency of KIR2DL5 + NK cells increases with the number of expressed KIR.

Furthermore, KIR2DL5 is preferentially co-expressed with KIR2DL1 and is negatively regulated by NKG2A. Of note, CD57 expression, regardless of the NK cell subset considered, is associated with reduced receptor expression, consistent with its reduced cytotoxic potential.

Furthermore, molecular interactions between NK cells and leukemic cells influence NK cell responses, particularly the inhibitory KIR2DL5-PVR axis. The integration of these data is of importance for the optimization of NK cell-based immunotherapies, as the selection of NK cell donors represents a key parameter for the improvement of these therapies.

论文信息

作者
Ferron E、Jullien M、Braud M、David G、Fourgeux C、Bastien M、Salameh P、Willem C
第一作者单位
Research Laboratory Etablissement Français du Sang, 44011, Nantes, France.France
通讯作者单位
Research Laboratory Etablissement Français du Sang, 44011, Nantes, France. christelle.retiere@efs.sante.fr.France
文献类型
非美国政府资助研究
期刊
Journal of clinical immunology2025 Jul 29
原文标识
PubMed 40728766 · DOI 10.1007/s10875-025-01913-y